SUSAN BOLAND: Open Payments
NPI 1588653091 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 45 payments from 19 companies in 2025. Trend: 2023 $992 · 2024 $1,072 · 2025 $858
Food & beverage: $858
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $176 |
| PFIZER INC. | 5 | $83 |
| Astellas Pharma US Inc | 3 | $65 |
| Lundbeck LLC | 2 | $54 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Lilly USA, LLC | 3 | $51 |
| Phathom Pharmaceuticals, Inc. | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| SANOFI-AVENTIS U.S. LLC | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
Products named: NURTEC ODT, Ozempic, REXULTI, Veozah, MOUNJARO, VOQUEZNA, Wegovy, Kerendia.
Industry payments across GA — which companies pay providers there.
